联合血管切除与重建在肝门部胆管癌外科治疗中的应用

陈志宇; 别平

doi:10.3969/j.issn.1001-5256.2016.07.011

联合血管切除与重建在肝门部胆管癌外科治疗中的应用

DOI: 10.3969/j.issn.1001-5256.2016.07.011

陈志宇,
别平

第三军医大学第一附属医院全军肝胆外科研究所

详细信息

中图分类号: R735.8
计量
- 文章访问数: 1846
- HTML全文浏览量: 32
- PDF下载量: 400
- 被引次数: 0
出版历程
- 收稿日期: 2016-03-21
- 出版日期: 2016-07-20

Clinical application of combined vascular resection and reconstruction in surgical treatment of hilar cholangiocarcinoma

Research Institute of Hepatobiliary Surgery,The First Hospital Affiliated to Third Military Medical University

摘要

摘要: 肝门部胆管癌的外科治疗是肝胆外科领域中最具挑战性的常规手术之一。而血管侵犯是导致肝门部胆管癌根治性切除率低的重要原因。目前,学者们普遍公认受侵犯的门静脉切除重建是提高肝门部胆管癌R0切除率以及远期生存率的关键因素。然而,对于肝动脉受侵犯以后是否行切除重建目前仍存争议。结合既往文献和本中心临床治疗实践,阐述了联合血管切除与重建在肝门部胆管癌外科治疗中的应用及前景。指出随着计算机辅助外科技术的进步,以及更多病例资料的总结,联合血管切除重建在肝门部胆管癌中的适应证及远期疗效等问题仍需要进一步探索和研究。
- 胆管肿瘤 /
- 肝动脉 /
- 门静脉 /
- 胆道外科手术
Abstract: The surgical treatment of hilar cholangiocarcinoma is one of the most challenging routine surgeries in the field of hepatobiliary surgery,and vascular invasion is an important reason for the low rate of radical resection in hilar cholangiocarcinoma. Currently,it is universally acknowledged that resection and reconstruction of the portal vein invaded is a key factor in improving R0 resection rate and long- term survival rate in patients with hilar cholangiocarcinoma. However,whether to perform resection and reconstruction after invasion of hepatic artery is still controversial. With reference to published literature and clinical practice in our center,this article introduces the application and prospects of combined vascular resection and reconstruction in the surgical treatment of hilar cholangiocarcinoma and points out that with the development of computer- assisted surgery and summarization of more and more case data,indications and long- term efficacy of combined vascular resection and reconstruction in the treatment of hilar cholangiocarcinoma await further investigation and research.
- bile duct neoplasms /
- hepatic artery /
- portal vein /
- biliary tract surgical procedures

HTML全文

参考文献(14)

[1] KAJITANI T,KUNO K,HISHIDA Y,et al.Surgical treatment for hepatic hilar carcinoma[J].Shujutsu,1966,20:997-1002.

[2]ZHOU NX,HUANG ZQ,LIU YX,et al.National survey of extrahepatic biliary tract cancer:an analysis of 1098 cases[J].Chin JSurg,1990,28(9):516-521.(in Chinese)周宁新,黄志强,刘永雄,等.肝外胆道癌全国调查1098例分析[J].中华外科杂志,1990,28(9):516-521.

[3]LIANG TB,BAI XL.Multidisciplinary team diagnosis and treatment o hilar cholangiocarcinoma[J].Chin J Dig Surg,2015,14(4):268-274.(in Chinese)梁廷波,白雪莉.肝门部胆管癌多学科团队的诊断与治疗[J].中华消化外科杂志,2015,14(4):268-274.

[4]TAMOTO E,HIRANO S,TSUCHIKAWA T,et al.Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma[J].HPB(Oxford),2014,16(1):56-61.

[5] WU XS,DONG P,GU J,et al.Combined portal vein resection for hilar cholangiocarcinoma:a meta-analysis of comparative studies[J].J Gastrointest Surg,2013,17(6):1107-1115.

[6]EBATA T,NAGINO M,KAMIYA J,et al.Hepatectomy with portal vein resection for hilar cholangiocarcinoma:audit of 52 consecutive cases[J].Ann Surg,2003,238(5):720-727.

[7]LEE SG,LEE J,PARK KM,et al.One hundred and eleven liver resections for hilar bile duct cancer[J].J Hepatobiliary Pancreat Surg,2000,7(7):135-141.

[8]SHIMADA H,ENDO I,SUGITA M,et al.Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder[J].World J Surg,2003,27(10):1137-1142.

[9] Biliary Tract Group,Chinese Society of Surgery,Chinese Medical Association.Specialized Committee on Hepatobiliary Surgery of PLA.Guidelines for the diagnosis and treatment of hilar cholangiocarcinoma(2013 edition)[J].Chin J Surg,2013,51(10):865-871.(in Chinese)中华医学会外科学分会胆道外科学组,解放军全军肝胆外科专业委员会.肝门部胆管癌诊断和治疗指南(2013版)[J].中华外科杂志,2013,51(10):865-871.

[10]FAN Y,WU SD.An excerpt of hilar cholangiocarcinoma:expert consensus statement[J].J Clin Hepatol,2015,31(10):1588-1591.(in Chinese)范莹,吴硕东.《2014年美国肝胆胰学会共识声明:肝门部胆管癌管理》摘译[J].临床肝胆病杂志,2015,31(10):1588-1591.

[11]YAN FH,LI WX,LUO XF.Value of computed tomography in the diagnosis and resect-ability evaluation of hilar cholangiocarcinoma[J].Chin J Dig Surg,2014,13(6):441-446.(in Chinese)严福华,李卫侠,罗先富.CT检查在肝门部胆管癌诊断与可切除性评估中的价值[J].中华消化外科杂志,2014,13(6):441-446.

[12] MANTEL HT,WIGGERS JK,VERHEIJ J.Lymph node micrometastases are associated with worse survival in patients with otherwise node-negative hilar cholangiocarcinoma[J].Ann Surg Oncol,2015,22(Suppl 3):s1107-s1115.

[13]YANG SZ.The role of computer-aided operative planning system in the management of hilar cholangiocarcinoma:current status and future research directions[J].Chin J Pract Surg,2013,33(1):47-50.(in Chinese)杨世忠.计算机辅助手术规划系统在肝门部胆管癌治疗中应用现状及展望[J].中国实用外科杂志,2013,33(1):47-50.

[14]SU ZJ,DUAN P,LIU CH,et al.Application of three-dimensional visualization system in the treatment of hilar cholangiocarcinoma[J].Chin J Dig Surg,2013,12(3):213-216.(in Chinese)苏昭杰,段朋,刘昌华,等.三维可视化系统在肝门部胆管癌治疗中的应用[J].中华消化外科杂志,2013,12(3):213-216.

施引文献

资源附件(0)

访问统计